Health Headlines: Global Pharma Updates and Challenges

A round-up of recent health news includes Trump’s perfect health declaration after an exam, China’s untouched pharma industry despite scrutiny, and Lilly’s $3.8 billion push into vaccines. Other highlights include IPO filings, insulin pump corrections, and escalating challenges in battling Ebola across regions.

The latest health headlines capture global developments, including U.S. President Donald Trump’s declaration of perfect health following his physical exam at Walter Reed National Military Medical Center. Meanwhile, China's thriving pharmaceutical industry remains unaffected by the heightened scrutiny on tech deals, as noted by JW Therapeutics' CEO.

Eli Lilly’s significant investment marks a strategic move into infectious disease prevention, as the company announces acquisitions totaling $3.8 billion. In parallel, cardiovascular drug developer Kardigan is moving towards a U.S. IPO, signaling a revitalization in biotech investments.

Amidst rising Ebola cases and challenges in containment, the World Health Organization warns of the epidemic outpacing response efforts in regions like the Democratic Republic of Congo and Uganda. Concurrently, FDA's relaxed regulations could soon broaden the market with new vaping and nicotine products.